S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
52-week Low Names To Tip The Upside Scale In Your Favor
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
52-week Low Names To Tip The Upside Scale In Your Favor
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
52-week Low Names To Tip The Upside Scale In Your Favor
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
52-week Low Names To Tip The Upside Scale In Your Favor
OTCMKTS:SBMFF

Sino Biopharmaceutical (SBMFF) Stock Forecast, Price & News

$0.37
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$0.37
▼
$0.37
50-Day Range
$0.37
▼
$0.45
52-Week Range
$0.37
▼
$0.63
Volume
N/A
Average Volume
1 shs
Market Capitalization
$6.96 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest

SBMFF stock logo

About Sino Biopharmaceutical (OTCMKTS:SBMFF) Stock

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

SBMFF Price History

SBMFF Stock News Headlines

September 13, 2023 | jp.reuters.com
Sino Biopharmaceutical Ltd
July 17, 2023 | investing.com
Sino Biopharmaceutical Ltd ADR (SBHMY)
September 23, 2023 | Behind the Markets (Ad)
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's
A small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer's, Parkinson's and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>>
May 30, 2023 | forbes.com
Sino-Forest
March 12, 2023 | finance.yahoo.com
Sino Biopharmaceutical Limited (1177.HK)
March 7, 2023 | msn.com
Sino Biopharm Wins CFIUS Approval for $161 Million F-Star Deal
January 26, 2023 | finance.yahoo.com
invoX Pharma and F-star Therapeutics issue Joint Statement
November 11, 2022 | seekingalpha.com
F-star Therapeutics: At A Discount Of >30% To Takeover Offer, With CFIUS Approval On The Horizon
September 23, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
August 28, 2022 | finance.yahoo.com
China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
July 18, 2022 | benzinga.com
Sino Biopharmaceutical (OTC:SBMFF), Short Interest Report
July 18, 2022 | benzinga.com
Sino Biopharmaceutical (OTC:SBMFF), Analyst Ratings, Price Targets, Predictions
June 26, 2022 | seekingalpha.com
Week In Review: invoX, A Sino Biopharm Company, To Pay $161 Million To Acquire F-Star
June 23, 2022 | benzinga.com
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
June 23, 2022 | marketwatch.com
Sino Biopharmaceutical Unit to Buy F-star Therapeutics for $161 Million >FSTX
June 23, 2022 | seekingalpha.com
Sino Biopharma to acquire F-star Therapeutics for $161M
June 23, 2022 | benzinga.com
F-star Therapeutics Shares Are Rallying Today - Read Why
January 12, 2022 | nasdaq.com
Sino Biopharmaceutical Ltd. (SBMFF)
August 31, 2021 | markets.businessinsider.com
Sino Biopharmaceutical is about to announce earnings — here's what Wall Street expects
August 5, 2021 | markets.businessinsider.com
Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China
December 18, 2020 | wsj.com
Sino Biopharmaceutical Ltd.
October 25, 2020 | msn.com
Opinion: Here’s why women fund managers regularly outperform men, based on newer research
August 2, 2020 | www.nasdaq.com
Sino Biopharmaceutical Ltd (SBMFF)
May 22, 2020 | finance.yahoo.com
Should We Worry About Sino Biopharmaceutical Limited's (HKG:1177) P/E Ratio?
April 23, 2020 | finance.yahoo.com
Chinese cancer drug developer Akeso banks on pharma tie-up in race with rivals amid record-setting Hong Kong IPO
April 22, 2020 | finance.yahoo.com
Vice Chairwoman of the Board Cheung Ling Cheng Just Bought A Handful Of Shares In Sino Biopharmaceutical Limited (HKG:1177)
April 1, 2020 | finance.yahoo.com
Sino Biopharmaceutical Limited Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next
See More Headlines
Receive SBMFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sino Biopharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

SBMFF Company Calendar

Today
9/23/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:SBMFF
Previous Symbol
NASDAQ:SBMFF
CUSIP
N/A
CIK
1604982
Web
www.sinobiopharm.com
Phone
852-2802-9886
Fax
852-2880-0847
Employees
26,079
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$3.43 billion
Price / Sales
2.03
Cash Flow
$0.04 per share
Price / Cash Flow
10.27
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
18,813,868,000
Free Float
N/A
Market Cap
$6.96 billion
Optionable
Not Optionable
Beta
0.45
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Ms. Y. Y. Tse (Age 31)
    Exec. Chairwoman of the Board
    Comp: $4.78M
  • Mr. Eric S. Y. Tse (Age 27)
    CEO & Exec. Director
    Comp: $3.14M
  • Mr. Ping Tse (Age 71)
    Founder & Sr. Exec. Vice Chairman
    Comp: $5.71M
  • Ms. Cheung Ling Cheng (Age 59)
    Exec. Vice Chairwoman of the Board
    Comp: $4.03M
  • Ms. Mingqin Li (Age 64)
    Sr. VP & Exec. Director
    Comp: $163.38k
  • Mr. Zhoushan Tian (Age 59)
    Exec. Director
    Comp: $246.97k
  • Mr. Hsin Tse (Age 53)
    Sr. VP & Exec. Director
    Comp: $794.14k
  • Ms. Chun Ling Li (Age 51)
    Chief Financial Officer
  • Sean Chen
    Chief Strategy Officer
  • Orphanides George
    Chief Scientific Advisor of invoX

Key Competitors

View All Competitors













SBMFF Stock - Frequently Asked Questions

How have SBMFF shares performed in 2023?

Sino Biopharmaceutical's stock was trading at $0.5850 at the start of the year. Since then, SBMFF stock has decreased by 36.8% and is now trading at $0.37.
View the best growth stocks for 2023 here.

Are investors shorting Sino Biopharmaceutical?

Sino Biopharmaceutical saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 9,174,500 shares, an increase of 131.9% from the August 15th total of 3,955,800 shares. Based on an average trading volume of 2,100 shares, the days-to-cover ratio is presently 4,368.8 days.
View Sino Biopharmaceutical's Short Interest.

What is Sino Biopharmaceutical's stock symbol?

Sino Biopharmaceutical trades on the OTCMKTS under the ticker symbol "SBMFF."

How do I buy shares of Sino Biopharmaceutical?

Shares of SBMFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sino Biopharmaceutical's stock price today?

One share of SBMFF stock can currently be purchased for approximately $0.37.

How much money does Sino Biopharmaceutical make?

Sino Biopharmaceutical (OTCMKTS:SBMFF) has a market capitalization of $6.96 billion and generates $3.43 billion in revenue each year.

How many employees does Sino Biopharmaceutical have?

The company employs 26,079 workers across the globe.

How can I contact Sino Biopharmaceutical?

Sino Biopharmaceutical's mailing address is Rm 4109 Office Tower Convention Plaza 1 Harbour Road Wanchai, Hong Kong K3, . The official website for the company is www.sinobiopharm.com. The company can be reached via phone at 852-2802-9886, via email at stephentse@sino-biopharm.com, or via fax at 852-2880-0847.

This page (OTCMKTS:SBMFF) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -